This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Singular Genomics Systems’s 8K filing here.
Singular Genomics Systems Company Profile
Singular Genomics Systems, Inc, a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables for applications comprising single cell gene expression and proteomics, in situ RNA sequencing, and spatial RNA and proteomics applications for tissue.
Recommended Stories
- Five stocks we like better than Singular Genomics Systems
- What does consumer price index measure?
- Dow Jones: A Relevant Benchmark or a Relic of the Past?
- How Can Investors Benefit From After-Hours Trading
- 3 Big-Name Stocks Just Announced Big-Time Dividend Increases
- Roth IRA Calculator: Calculate Your Potential Returns
- Market Overreaction: 2 Stocks to Buy on the Way Down
